| P50 | author | Harri Mustonen | Q46423969 |
| | Camilla Böckelman | Q50969187 |
| | Jaana Hagström | Q57009230 |
| | Caj Haglund | Q89637823 |
| P2093 | author name string | Olle Nilsson | |
| | Christian Fermér | |
| | Tuomas Kaprio | |
| P2860 | cites work | The CD34-related molecule podocalyxin is a potent inducer of microvillus formation | Q21562330 |
| | The transcriptome profile of human embryonic stem cells as defined by SAGE | Q24302502 |
| | Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7 | Q24306767 |
| | Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin | Q24310542 |
| | Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells | Q24653465 |
| | Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer | Q27496689 |
| | Cancer statistics, 2012 | Q27860574 |
| | Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin | Q28198230 |
| | Cancer cells in transit: the vascular interactions of tumor cells | Q28243610 |
| | Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression | Q28275243 |
| | Podocalyxin variants and risk of prostate cancer and tumor aggressiveness | Q28293538 |
| | Podocalyxin is a CD34-related marker of murine hematopoietic stem cells and embryonic erythroid cells | Q28512394 |
| | Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 |
| | Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition | Q33886903 |
| | A human protein atlas for normal and cancer tissues based on antibody proteomics | Q34446479 |
| | Podocalyxin is a marker of poor prognosis in colorectal cancer | Q34485223 |
| | Adjuvant chemotherapy for stage II colon cancer with poor prognostic features | Q34631210 |
| | The role of podocalyxin in health and disease | Q34990690 |
| | Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer. | Q35287580 |
| | Microdomains of distinctive glycoprotein composition in the kidney proximal tubule brush border | Q36210654 |
| | Sialofucosylated podocalyxin is a functional E- and L-selectin ligand expressed by metastatic pancreatic cancer cells | Q36308972 |
| | Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer | Q36924797 |
| | Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin | Q40110305 |
| | Endothelial cell membranes contain podocalyxin--the major sialoprotein of visceral glomerular epithelial cells | Q41498433 |
| | The Human Protein Atlas--a tool for pathology | Q46431300 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| | colorectal carcinoma | Q25493920 |
| P304 | page(s) | 494 | |
| P577 | publication date | 2014-07-08 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | A comparative study of two PODXL antibodies in 840 colorectal cancer patients | |
| P478 | volume | 14 | |